Yale holds d4T patent, invention funded by NIH Grant CA-28852

[James Love <love@cptech.org>]

This is from the d4T patent, which is held by Yale University, and
licensed to Bristol-Myers Squibb.  d4T is a very important HIV drug,
that is used in low end HIV cocktails.  It is one of the key drugs for
compulsory licensing.   As indicated on the patent application, the US
government funded this invention with NIH Grant CA-28852, and has
certain rights to the invention, including Bayh-Dole "March-In" rights
under 35 USC 203. 


You can find the patent using this USPTO search engine:

http://164.195.100.11/netahtml/srchnum.htm


 United States Patent  4,978,655
 Lin ,   et al. 
 December 18, 1990 

Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in
treating patients infected with retroviruses 

          Abstract

This invention relates to the use of 3'-deoxythymidin-2'-ene
(3'deoxy-2',3'-didehydrothymidine) in treating patients infected with a
retrovirus. 


 Inventors:  Lin; Tai-Shun (North Haven, CT); Prusoff; William H. (North
Branford, CT) 
 Assignee:  Yale University (New Haven, CT) 
 Appl. No.:  942666
 Filed: December 17, 1986
 U.S. Class:        514/50; 514/934 
 Intern'l Class:    A61K 031/70

   [snip] 

This invention was made with United States government support under
Grant CA-28852 from the NIH. The United States Government has certain
rights in this invention. 


Primary Examiner: Rollins; John W. 
Attorney, Agent or Firm: Sprung Horn Kramer & Woods 

Goverment Interests

GOVERNMENT RIGHTS 

This invention was made with United States government support under
Grant CA-28852 from the NIH. The United States Government has certain
rights in this invention. 

-- 
James Love, Director, Consumer Project on Technology
I can be reached at love@cptech.org, by telephone 202.387.8030,
by fax at 202.234.5176. CPT web page is http://www.cptech.org